A phase I/II trial of DEP® Cabazitaxel
Not yet recruiting
Phase of Trial: Phase I/II
Latest Information Update: 31 Jan 2018
At a glance
- Drugs Cabazitaxel (Primary)
- Indications Breast cancer; Solid tumours
- Focus Adverse reactions; Therapeutic Use
- 31 Jan 2018 Status changed from planning to not yet recruiting according to a Starpharma media release.
- 31 Jan 2018 According to a Starpharma media release, the company has received regulatory and ethics approval to commence this trial.
- 30 Jan 2018 Patient gender and indiacation are assumed from RDI.